These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 17416532)

  • 41. Dendrimers as versatile platform in drug delivery applications.
    Svenson S
    Eur J Pharm Biopharm; 2009 Mar; 71(3):445-62. PubMed ID: 18976707
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeted prodrugs in oral drug delivery: the modern molecular biopharmaceutical approach.
    Dahan A; Khamis M; Agbaria R; Karaman R
    Expert Opin Drug Deliv; 2012 Aug; 9(8):1001-13. PubMed ID: 22703376
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Designing libraries of first generation AB3 and AB2 self-assembling dendrons via the primary structure generated from combinations of (AB)(y)-AB3 and (AB)(y)-AB2 building blocks.
    Percec V; Mitchell CM; Cho WD; Uchida S; Glodde M; Ungar G; Zeng X; Liu Y; Balagurusamy VS; Heiney PA
    J Am Chem Soc; 2004 May; 126(19):6078-94. PubMed ID: 15137774
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Optimizing delivery of flurbiprofen to the colon using a targeted prodrug approach.
    Philip AK; Dubey RK; Pathak K
    J Pharm Pharmacol; 2008 May; 60(5):607-13. PubMed ID: 18416937
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Controlled assembly of peptide nanotubes triggered by enzymatic activation of self-immolative dendrimers.
    Adler-Abramovich L; Perry R; Sagi A; Gazit E; Shabat D
    Chembiochem; 2007 May; 8(8):859-62. PubMed ID: 17457816
    [No Abstract]   [Full Text] [Related]  

  • 46. Biomedical applications of dendrimers: a tutorial.
    Mintzer MA; Grinstaff MW
    Chem Soc Rev; 2011 Jan; 40(1):173-90. PubMed ID: 20877875
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prodrug approaches for CNS delivery.
    Rautio J; Laine K; Gynther M; Savolainen J
    AAPS J; 2008; 10(1):92-102. PubMed ID: 18446509
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Real-time monitoring of drug release.
    Weinstain R; Segal E; Satchi-Fainaro R; Shabat D
    Chem Commun (Camb); 2010 Jan; 46(4):553-5. PubMed ID: 20062859
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fast Cyclization of a Proline-Derived Self-Immolative Spacer Improves the Efficacy of Carbamate Prodrugs.
    Dal Corso A; Borlandelli V; Corno C; Perego P; Belvisi L; Pignataro L; Gennari C
    Angew Chem Int Ed Engl; 2020 Mar; 59(10):4176-4181. PubMed ID: 31881115
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A doxorubicin prodrug activated by the staudinger reaction.
    van Brakel R; Vulders RC; Bokdam RJ; Grüll H; Robillard MS
    Bioconjug Chem; 2008 Mar; 19(3):714-8. PubMed ID: 18271515
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activity-Based Optical Sensing Enabled by Self-Immolative Scaffolds: Monitoring of Release Events by Fluorescence or Chemiluminescence Output.
    Gnaim S; Shabat D
    Acc Chem Res; 2019 Oct; 52(10):2806-2817. PubMed ID: 31483607
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modulating the therapeutic activity of nanoparticle delivered paclitaxel by manipulating the hydrophobicity of prodrug conjugates.
    Ansell SM; Johnstone SA; Tardi PG; Lo L; Xie S; Shu Y; Harasym TO; Harasym NL; Williams L; Bermudes D; Liboiron BD; Saad W; Prud'homme RK; Mayer LD
    J Med Chem; 2008 Jun; 51(11):3288-96. PubMed ID: 18465845
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design, synthesis, and cyclization of 4-aminobutyric acid derivatives: potential candidates as self-immolative spacers.
    DeWit MA; Gillies ER
    Org Biomol Chem; 2011 Mar; 9(6):1846-54. PubMed ID: 21267507
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prodrug strategies to overcome poor water solubility.
    Stella VJ; Nti-Addae KW
    Adv Drug Deliv Rev; 2007 Jul; 59(7):677-94. PubMed ID: 17628203
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thermoresponsive and biodegradable linear-dendritic nanoparticles for targeted and sustained release of a pro-apoptotic drug.
    Stover TC; Kim YS; Lowe TL; Kester M
    Biomaterials; 2008 Jan; 29(3):359-69. PubMed ID: 17964645
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeting the delivery of glycan-based paclitaxel prodrugs to cancer cells via glucose transporters.
    Lin YS; Tungpradit R; Sinchaikul S; An FM; Liu DZ; Phutrakul S; Chen ST
    J Med Chem; 2008 Dec; 51(23):7428-41. PubMed ID: 19053781
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Perspectives About Self-Immolative Drug Delivery Systems.
    Gonzaga RV; do Nascimento LA; Santos SS; Machado Sanches BA; Giarolla J; Ferreira EI
    J Pharm Sci; 2020 Nov; 109(11):3262-3281. PubMed ID: 32860799
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A family of hierarchically self-assembling linear-dendritic hybrid polymers for highly efficient targeted gene delivery.
    Wood KC; Little SR; Langer R; Hammond PT
    Angew Chem Int Ed Engl; 2005 Oct; 44(41):6704-8. PubMed ID: 16173106
    [No Abstract]   [Full Text] [Related]  

  • 59. Self-Immolative Linkers Literally Bridge Disulfide Chemistry and the Realm of Thiol-Free Drugs.
    Riber CF; Smith AA; Zelikin AN
    Adv Healthc Mater; 2015 Aug; 4(12):1887-90. PubMed ID: 26109168
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prodrugs: Some thoughts and current issues.
    Stella VJ
    J Pharm Sci; 2010 Dec; 99(12):4755-65. PubMed ID: 20821387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.